Device type · QKP
Coronavirus Antigen Detection Test System.
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QKP
Microbiology
Device class
Not classified
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
227
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Coronavirus Antigen Detection Test System.
- Product code
- QKP
- Device class
- Not classified
- Review panel
- Microbiology
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for QKP
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
227
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
223
98% of reports
Injury reports
4
1.8% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 148 | 0 | 0 | 0 |
| Jan 24 | 229 | 17 | 0 | 0 |
| Feb 24 | 130 | 4 | 0 | 0 |
| Mar 24 | 84 | 0 | 0 | 0 |
| Apr 24 | 36 | 1 | 0 | 0 |
| May 24 | 48 | 0 | 0 | 0 |
| Jun 24 | 37 | 1 | 0 | 0 |
| Jul 24 | 88 | 2 | 0 | 0 |
| Aug 24 | 127 | 3 | 0 | 0 |
| Sep 24 | 123 | 2 | 0 | 0 |
| Oct 24 | 170 | 7 | 0 | 1 |
| Nov 24 | 150 | 2 | 0 | 0 |
| Dec 24 | 141 | 3 | 0 | 0 |
| Jan 25 | 112 | 2 | 0 | 0 |
| Feb 25 | 81 | 2 | 0 | 0 |
| Mar 25 | 60 | 0 | 0 | 0 |
| Apr 25 | 215 | 0 | 0 | 0 |
| May 25 | 24 | 0 | 0 | 1 |
| Jun 25 | 16 | 0 | 0 | 0 |
| Jul 25 | 18 | 0 | 0 | 0 |
| Aug 25 | 99 | 0 | 0 | 0 |
| Sep 25 | 72 | 1 | 0 | 0 |
| Oct 25 | 28 | 0 | 0 | 0 |
| Nov 25 | 10 | 0 | 0 | 0 |
| Dec 25 | 13 | 1 | 0 | 0 |
| Jan 26 | 18 | 0 | 0 | 0 |
| Feb 26 | 21 | 2 | 0 | 0 |
| Mar 26 | 16 | 0 | 0 | 0 |
| Apr 26 | 9 | 0 | 0 | 0 |
| May 26 | 6 | 1 | 0 | 0 |
| Jun 26 | 6 | 0 | 0 | 0 |
| Jul 26 | 17 | 0 | 0 | 0 |
| Aug 26 | 22 | 0 | 0 | 0 |
| Sep 26 | 30 | 0 | 0 | 0 |
| Oct 26 | 55 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
5 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Unable to Obtain Readings174
- No Apparent Adverse Event25
- False Positive Result20
4 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Insufficient Information191
- No Clinical Signs, Symptoms or Conditions36
- Distress2
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Guangzhou Pluslife Biotech Co., Ltd.
Z-1978-2025 · Started Jan 24, 2025 · Posted by FDA Jun 13, 2025
Reason given: Devices were distributed in the U.S. market without obtaining the required FDA premarket authorization (e.g., 510(k) clearance or PMA).
Cause as FDA categorized it: No Marketing Application
Guangzhou Pluslife Biotech Co., Ltd.
Z-1979-2025 · Started Jan 24, 2025 · Posted by FDA Jun 13, 2025
Reason given: Devices were distributed in the U.S. market without obtaining the required FDA premarket authorization (e.g., 510(k) clearance or PMA).
Cause as FDA categorized it: No Marketing Application
- Pilot COVID-19 At-Home Test, Reference Number 9901-NCOV-10G, Catalog Number 99COV200L-EN02, UPC Code: 887473000207 (EAN-13: 08800111707728)Open, Classified
Z-1594-2023 · Started Mar 31, 2023 · Posted by FDA May 23, 2023
Reason given: The liquid buffer component in the affected test kit lots was determined to have bacterial contamination. User may notice a slight odor when the buffer is brought close to the nose.
Cause as FDA categorized it: Material/Component Contamination
44 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.